Evidence map›Paper›PMID 41746044›Full record

ArticleVaccines2026

Dose-Dependent Efficacy of a Riboflavin and Ultraviolet Light-Inactivated Whole-Virion SARS-CoV-2 Vaccine in a Hamster Infection Challenge Model.

Noelia Altina, Izabela K Ragan, Kimberly A Arnett, Socks Jones, Arielle Glass, Taru S Dutt, Andres Obregon-Henao, Pablo Maldonado, Mac Harris, Richard A Bowen and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Noelia AltinaDepartment of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Izabela K RaganDepartment of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.ORCID 0000-0002-1379-6015
Kimberly A ArnettDepartment of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Socks JonesDepartment of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Arielle GlassDepartment of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Taru S DuttDepartment of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA.ORCID 0000-0002-5101-1311
Andres Obregon-HenaoDepartment of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Pablo MaldonadoDepartment of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Mac HarrisDepartment of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Richard A BowenDepartment of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Nicole Kruh-GarciaBioMARC, Infectious Disease Research Center, Colorado State University, Fort Collins, CO 80521, USA.
Darragh HeaslipBioMARC, Infectious Disease Research Center, Colorado State University, Fort Collins, CO 80521, USA.
Susan YonemuraIndependent Researcher, Fort Collins, CO 80526, USA.ORCID 0000-0002-0121-7987
Marcela Henao-TamayoDepartment of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA.ORCID 0000-0002-4249-9650
Raymond P GoodrichDepartment of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA.ORCID 0000-0002-5945-4571

Funding

To Develop and Manufacture an Inactivated SARS-CoV-2 Vaccine Using Blood Pathogen Reduction Technology75N93020C00053 · NIAID · COLORADO STATE UNIVERSITY · PI GOODRICH, RAYMOND · 2020 to 2024
$6.3M
Biomedical Advanced Research and Development Authority 75A50120C00131NIAID NIH HHS 75N93020C00053
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19CpG1018 adjuvanthamster modelneutralizing antibodiesriboflavin–UV inactivationSARS-CoV-2vaccine

Identifiers

PMID41746044
PMCPMC12945153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.